- van der Laan Anja M., Schirmer Stephan H., de Vries Margreet R., Koning Jasper J., Volger Oscar L., Fledderus Joost O., Bastiaansen Antonius J. N. M., Hollander Maurits R., Baggen Josefien M., Koch Karel T., Baan Jan, Henriques José P., van der Schaaf René J., Vis Marije M., Mebius Reina E., van der Pouw Kraan Tineke C., Quax Paul H., Piek Jan J., Horrevoets Anton J., van Royen Niels Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis European heart journal 2012;33 (9):1076-1084 [PubMed]
- van der Laan Anja M., Hirsch Alexander, Haeck Joost D. E., Nijveldt Robin, Delewi Ronak, Biemond Bart J., Tijssen Jan G. P., Marques Koen M. J., Zijlstra Felix, van Rossum Albert C., Piek Jan J. Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial JACC. Cardiovascular interventions 2011;4 (8):913-920 [PubMed]
- Schirmer Stephan H., Bot Pieter T., Fledderus Joost O., van der Laan Anja M., Volger Oscar L., Laufs Ulrich, Boehm Michael, de Vries Carlie J. M., Horrevoets Anton J. G., Piek Jan J., Hoefer Imo E., van Royen Niels Blocking Interferon beta Stimulates Vascular Smooth Muscle Cell Proliferation and Arteriogenesis Journal of biological chemistry 2010;285 (45):34677-34685 [PubMed]
- van der Laan Anja M., Piek Jan J., van Royen Niels Targeting angiogenesis to restore the microcirculation after reperfused MI Nature reviews. Cardiology 2009;6 (8):515-523 [PubMed]
- van der Laan A., Hirsch A., Nijveldt R., van der Vleuten P. A., van der Giessen W. J., Doevendans P. A., Waltenberger J., ten Berg J. M., Aengevaeren W. R. M., Zwaginga J. J., Biemond B. J., van Rossum A. C., Tijssen J. G. P., Zijlstra F., Piek J. J. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results Netherlands heart journal 2008;16 (12):436-439 [PubMed]
Personal Details
Name: Anja M. van der Laan
Date and Place of Birth: 6th March 1982, Beverwijk
Nationality: Dutch
Education
2000-2007: Medicine, University of Amsterdam, Amsterdam, The Netherlands
2000-2004: SUPER-program: extra-curricular program for selected students, University of Amsterdam, Amsterdam, The Netherlands
2004: Research internship, Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, USA. Supervisor: S.J. Fisher, PhD.
Professional experience
2007-present: Research fellow, Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands: "The role of monocytes in acute and chronic coronary artery disease." Supervisors: J.J. Piek, MD, PhD, A.J. Horrevoets, PhD, N. van Royen, MD, PhD, and A. Hirsch, MD, PhD.
2007–present: Study coordinator of the Hebe trial, Department of Cardiology, Academic Medical Center, Amsterdam and the Interuniversity Cardiology Institute of the Netherlands, Utrecht: “Bone marrow mononuclear cell therapy in patients with acute myocardial infarction.”